Kristin Wiisanen, Pharm.D., FAPhA, FCCP
Clinical Professor And Associate Dean For Entrepreneurial Programs; Associate Director Of The UF Health Precision Medicine Program; Director Of The Graduate Program In Precision Medicine
Department:
Entrepreneurial Programs
Business Phone:
(352) 273-5114
Business Email:
kwiisanen@cop.ufl.edu
About Kristin Wiisanen
Kristin Wiisanen received her PharmD from the University of Florida in 1998 and completed residency training at the Medical College of Virginia. Dr. Wiisanen is a Clinical Professor and Associate Dean for Entrepreneurial Programs in the UF College of Pharmacy. She is Associate Director of the University of Florida Health (UF Health) Precision Medicine Program and Director of the Graduate Program in Precision Medicine. Dr. Wiisanen leads clinical and educational efforts for pharmacogenomics in the UF Health Precision Medicine Program and serves as Residency Program Director for an accredited postgraduate Clinical Pharmacogenetics Residency and Director of the Clinical Fellowship in Pharmacogenomics program. She is Editor-in-Chief of Pharmacy Today for the American Pharmacists Association (APhA), a fellow of APhA and the American College of Clinical Pharmacy, and a University of Florida Entrepreneurial Faculty Fellow.
Teaching Profile
Courses Taught
2019-2020,2022
PHA6746 Patient Education and Communication in the Era of Precision Medicine
2020-2023
PHA6935 Selected Topics in Pharmacy
2019-2021
PHA6950 Precision Medicine Conference
2019-2021
PHA5929 UF Precision Medicine Conference
2018-2019
PHA5012 App Personalized Med
2019,2021
PHA5789C Patient Care 7
2018
PHA5878C Pt Care 3: Cv and Pulm
2018
PHA5784C Pt Care 4: GI and Renal
2014-2016
PHA5933 Select Top Pharmacy
2016
PHA5701C Person and Prof Dev II
2012-2015
PHA5788 Pharmacotherapy 6
2011-2013
PHA5784 Pharmacotherapy 4
2012-2013
PHA5108L Pharmaceu Skls Lab 1
2011-2013
PHA5782 Pharmacotherapy 2
2011,2013
PHA6634 Mtm: Endocrine Focus
2013
PHA5781 Pharmacotherapy 1
2012-2013
PHA5787 Pharmacotherapy 5
2013
PHA5907 Research in Phar Prac
2021
PHA6910 Supervised Research
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-4946-7504
Publications
2022
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.
Implementation science communications.
3(1)
[DOI] 10.1186/s43058-022-00300-7.
[PMID] 35568931.
2022
How to implement a pharmacogenetics service at your institution
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.
5(11):1161-1175
[DOI] 10.1002/jac5.1699.
[PMID] 36589694.
2022
Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators.
Clinical and translational science.
15(10):2479-2492
[DOI] 10.1111/cts.13376.
[PMID] 35899435.
2022
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
Clinical and translational science.
15(2):371-383
[DOI] 10.1111/cts.13154.
[PMID] 34562070.
2022
Overview of effective pharmacogenomic clinical decision support
Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation.
1(1):3-16
2022
Patient-facing clinical decision support
Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation.
1(1):203-221
2022
The importance of phenoconversion when using the CYP2D6 genotype in clinical practice
Pharmacogenomics.
23(14):749-752
[DOI] 10.2217/pgs-2022-0087.
[PMID] 36102178.
2021
Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
Clinical and translational science.
14(2):589-598
[DOI] 10.1111/cts.12914.
[PMID] 33166056.
2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.
The pharmacogenomics journal.
21(6):657-663
[DOI] 10.1038/s41397-021-00244-6.
[PMID] 34075203.
2021
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.
Genetics in medicine : official journal of the American College of Medical Genetics.
23(7):1185-1191
[DOI] 10.1038/s41436-021-01118-9.
[PMID] 33782552.
2021
Evaluating an interactive teaching approach with personal genotyping to provide pharmacy students with a knowledge base for clinical pharmacogenetics.
Journal of the American College of Clinical Pharmacy.
4:343-351
[DOI] 10.1002/jac5.1335.
2021
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.
Clinical pharmacology and therapeutics.
110(3):677-687
[DOI] 10.1002/cpt.2354.
[PMID] 34231197.
2021
Improving Patient Outcomes Through the Integration of Pharmacogenomic Testing into Comprehensive Medication Management Care Models
The Journal of Precision Medicine.
7(3):28-37
2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics.
23(12):2335-2341
[DOI] 10.1038/s41436-021-01269-9.
[PMID] 34282303.
2021
The pharmacist’s responsibility to ensure appropriate use of direct-to-consumer genetic testing
Journal of the American College of Clinical Pharmacy.
2021(4):652-658
[DOI] 10.1002/jac5.1437.
2021
Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
Journal of Personalized Medicine.
11(11)
[DOI] 10.3390/jpm11111227.
[PMID] 34834578.
2020
Competency-based clinical pharmacogenomics activities during an advanced pharmacy practice experience
Journal of the American College of Clinical Pharmacy.
4:60-70
[DOI] 10.1002/jac5.1363.
2020
<p>Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network</p>
Pharmacogenomics and Personalized Medicine.
Volume 13:217-226
[DOI] 10.2147/pgpm.s241599.
2020
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Journal of clinical medicine.
9(7)
[DOI] 10.3390/jcm9072274.
[PMID] 32708920.
2017
Institutional profile: University of Florida Health Personalized Medicine Program.
Pharmacogenomics.
18(5):421-426
[DOI] 10.2217/pgs-2017-0028.
[PMID] 28346068.
2016
Educational strategies to enable expansion of pharmacogenomics-based care.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
73(23):1986-1998
[PMID] 27864206.
2016
The IGNITE network: a model for genomic medicine implementation and research.
BMC medical genomics.
9
[DOI] 10.1186/s12920-015-0162-5.
[PMID] 26729011.
2014
Clinical pharmacogenetics implementation: approaches, successes, and challenges.
American journal of medical genetics. Part C, Seminars in medical genetics.
166C(1):56-67
[DOI] 10.1002/ajmg.c.31390.
[PMID] 24616371.
2014
Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Pharmacotherapy.
34(10):1102-12
[DOI] 10.1002/phar.1481.
[PMID] 25220280.
2013
Development of a Novel Pgy2 Pharmacogenomics and Drug Information Residency in a Personalized Medicine Program
Pharmacotherapy.
33
2012
Teaching clinical problem solving: a preceptor’s guide.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
69(18):1588-99
[DOI] 10.2146/ajhp110521.
[PMID] 22935942.
2004
Pharmacist-managed headache clinic.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
61(23):2548-50
[PMID] 15595231.
2001
Gender-specific issues in the treatment of migraine.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
4(1):64-74
[PMID] 11324243.
2000
Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Clinical therapeutics.
22(11):1254-67
[PMID] 11117652.
Grants
Jul 2019
– Jun 2022
Expansion of the Phamacogentics (PGx) Consultation Clinic to Family Medicine
Role: Co-Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Education
PGY1- Residency
1998-1999
·
Virginia Commonwealth University/Medical College of Virginia
Pharm.D.
1998
·
University of Florida
A.A.
1994
·
University of North Florida
Contact Details
Phones:
- Business:
- (352) 273-5114
Emails:
- Business:
- kwiisanen@cop.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100486
GAINESVILLE FL 32610 - Business Street:
-
HPNP BUILDING 212
HPNP BUILDING 212
101 S. NEWELL DRIVE
GAINESVILLE FL 326100001